SCHEMBL6663817

SCHEMBL6663817

OCC/C=C/c1cncc(-c2ccccc2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 2/20 0.41
MKNK1 Q9BUB5 1/20 0.40
MKNK2 Q9HBH9 1/20 0.40
FDPS P14324 3/20 0.38
TBXAS1 P24557 1/20 0.38
HDAC1 Q13547 2/20 0.37
CYP11B1 P15538 4/20 0.37
CYP11B2 P19099 4/20 0.37
ATM Q13315 1/20 0.36
KDM1A O60341 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
FNTA P49354 1/20 0.36
FNTB P49356 1/20 0.36
CHRNA7 P36544 2/20 0.35
CHRNB2 P17787 1/20 0.35
CHRNB4 P30926 1/20 0.35
CHRNA3 P32297 1/20 0.35
CHRNA4 P43681 1/20 0.35
MEN1 O00255 1/20 0.35
CYP2D6 P10635 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8427305 1.00 PTGS2 (0.41) PTGS2MKNK1MKNK2FDPSTBXAS1
SCHEMBL6659860 0.81 CHRNB2 (0.58) PTGS2MKNK1MKNK2HDAC1CYP11B1
SCHEMBL7224789 0.81 CHRNB2 (0.58) PTGS2MKNK1MKNK2HDAC1CYP11B1
SCHEMBL11879177 0.78 CA1 (0.50) HDAC1HDAC6CYP2D6CYP2C9CYP2C19
SCHEMBL11884294 0.78 CA1 (0.50) HDAC1HDAC6CYP2D6CYP2C9CYP2C19
SCHEMBL6662274 0.78 CHRNB2 (0.43) PTGS2MKNK2CHRNA7CHRNB2CHRNB4
SCHEMBL4822196 0.75 PTGS2 (0.42) PTGS2MKNK1MKNK2FDPSHDAC1
SCHEMBL6666536 0.75 AKT1 (0.48) MKNK2CHRNA7CHRNB2CHRNB4CHRNA3
SCHEMBL9000337 0.73 CYP11B1 (0.44) PTGS2MKNK1MKNK2HDAC1CYP11B1
SCHEMBL1301624 0.73 PAM (0.54) HDAC1HDAC6CYP2D6CYP2C9CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0973743-B1 PHARMACEUTICAL COMPOSITIONS INCORPORATING ARYL SUBSTITUTED OLEFINIC AMINE COMPOUNDS TARGACEPT INC (US) 2004-08-25 EP disclosed
US-6531606-B1 Nicotinic compound: N-methyl-4-(3-(5-phenylpyridin)yl)-3-buten-1-amine; capable of affecting nicotinic chlorinergic receptors TARGACEPT, INC. 2003-03-11 US disclosed
US-6274606-B1 ADMINISTERING COMPOUNDS SUCH AS (E)-N-METHYL-4-(3-(5-ISO PROPOXYPYRIDIN)YL)-3-BUTEN-1-AMINE TO TREAT PARKINSON'S DISEASE, TOURETTE'S SYNDROME, ATTENTION DEFICIT DISORDER, SCHIZOPHRENIA, AND ALZHEIMER'S DISEASE TARGACEPT, INC. 2001-08-14 US disclosed
EP-0973743-A1 PHARMACEUTICAL COMPOSITIONS INCORPORATING ARYL SUBSTITUTED OLEFINIC AMINE COMPOUNDS R.J. REYNOLDS TOBACCO COMPANY (US) 2000-01-26 EP disclosed
WO-1998037071-A1 PHARMACEUTICAL COMPOSITIONS INCORPORATING ARYL SUBSTITUTED OLEFINIC AMINE COMPOUNDS R.J. REYNOLDS TOBACCO COMPANY (US) 1998-08-27 WO disclosed